Skip to main content
SpringerLink
Log in

Modulators of cellular protein phosphorylation alter thetrans-activation function of human progesterone receptor and the biological activity of progesterone antagonists

  • William L. McGuire Memorial Symposium
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Addition of progesterone to breast cancer cellsin vivo increases phosphorylation of human progesterone receptor (PR), suggesting that phosphorylation has a regulatory role in producing the activated form of receptor. Kinetic analysis indicates that hormone-dependent phosphorylation is sequential and that early stages of phosphorylation(s) are closely associated with enhancement of PR-DNA binding while later stages are associated with atrans-activation function. Various agents that stimulate cellular protein phosphorylation (8-Br cAMP, okadaic acid, TPA) functionally synergize with progesterone to enhance progesterone-dependent PRtrans-activation in intact cells. These results suggest that protein phosphorylation does have a role in modulating thetrans-activation function of PRin vivo. They also demonstrate cross-talk between second messenger signal transduction pathways and nuclear steroid receptors. Whether the phosphorylated target that provides the link between these two signal transduction pathways is PR itself or another protein involved in PR-mediated gene transcription is not known. Positive cooperative interactions were also observed between cAMP signaling pathways and the progesterone antagonist RU486, that resulted in RU486 exerting substantial agonist activities. This ability of cross-talk between second messenger and steroid receptor signal transduction pathways to override the antagonistic effects of RU486 suggests a novel mechanism to explain the problem of resistance to clinically important steroid antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Evans RM: The steroid/thyroid receptor gene family. Science 240:889–894, 1988

    Google Scholar 

  2. Carson-Jurica A, Schrader WT, O'Malley BW: Steroid receptor family: Structure and functions. Endocrine Rev 11:201–22, 1990

    Google Scholar 

  3. Orti E, Bodwell JE, Munck A: Phosphorylation of steroid hormone receptors. Endocrine Rev 13:105–128, 1992

    Google Scholar 

  4. Moudgil VK: Phosphorylation of steroid hormone receptors. Biochim Biophys Acta Mol Cell Res 1055: 243–258, 1990

    Google Scholar 

  5. Migliacco A, DiDomenico M, Green S, deFalco A, Kajtaniak EL, Blasi F, Chambon P, Auricchio F: Phosphorylation of tyrosine ofin vitro synthesized human estrogen receptor activates its hormone binding. Mol Endocrinol 3:1061–1069, 1989

    Google Scholar 

  6. Rochette-Egly C, Gaub M-P, Lutz Y, Ali S, Scheuer I, Chambon P: Retinoic acid receptor β: Immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol 6:2197–2209, 1992

    Google Scholar 

  7. Denton RR, Koszewski NJ, Notides AC: Estrogen receptor phosphorylation. J Biol Chem 267:7263–7268, 1992

    Google Scholar 

  8. Washburn T, Hocutt A, Brautigan DL, Korach KS: Uterine estrogen receptorin vivo: phosphorylation at nuclear specific forms on serine residues. Mol Endocrinol 5:235–242, 1991

    Google Scholar 

  9. Denner LA, Schrader WT, O'Malley BW, Weigel NL: Hormonal regulation and identification of chicken progesterone receptor phosphorylation sites. J Biol Chem 265:16548–16555, 1990

    Google Scholar 

  10. Bodwell JE, Orti E, Coull JM, Pappin DJC, Smith LI, Swift F: Identification of phosphorylated sites in the mouse glucocorticoid receptor. J Biol Chem 266: 7549–7555, 1991

    Google Scholar 

  11. Denner LA, Weigel NL, Schrader WT, O'Malley BW: Hormone dependent regulation of chicken progesterone receptor deoxyribonucleic acid binding and phosphorylation. Endocrinology 125:3051–3058, 1989

    Google Scholar 

  12. Edwards DP, DeMarzo AM, Oñate SA, Beck CA, Estes PA, Nordeen SK: Mechanisms controlling steroid receptor binding to specific DNA sequences. Steroids 56:271–278, 1991

    Google Scholar 

  13. DeMarzo AM, Beck CA, Oñate SA, Edwards DP: Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90 kDa heat shock protein. Proc Natl Acad Sci USA 88:72–76, 1991

    Google Scholar 

  14. Sheridan PL, Krett NL, Gordon JA, Horwitz KB: Human progesterone receptor transformation and nuclear down regulation are independent of phosphorylation. Mol Endocrinol 2:1329–1342, 1988

    Google Scholar 

  15. Hoeck W, Rusconi S, Groner B: Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. J Biol Chem 264:14396–14402, 1989

    Google Scholar 

  16. Takimoto GS, Tasset DM, Eppert AC, Horwitz KB: Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: Analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci 89:3050–3054, 1992

    Google Scholar 

  17. Bagchi MK, Tsai S-Y, Tsai M-J, O'Malley BW: Ligand and DNA-dependent phosphorylation of human progesterone receptorin vitro. Proc Natl Acad Sci USA 89:2664–2668, 1992

    Google Scholar 

  18. Denner LA, Weigel NL, Maxwell ML, Schrader WT, O'Malley BW: Regulation of progesterone receptor mediated transcription by phosphorylation. Science 250:1740–1743, 1990

    Google Scholar 

  19. Aronica SM, Katzenellenbogen BS: Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3'5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 128:2045–2052, 1991

    Google Scholar 

  20. Power RF, Lydon JP, Conneely OM, O'Malley BW: Dopamine activation of an orphan of the steroid receptor superfamily. Science 252:1546–1548, 1991

    Google Scholar 

  21. Power RF, Many SK, Codeina J, Conneely OM, O'Malley BW: Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636–1639, 1991

    Google Scholar 

  22. Jordan VC, Murphy CS: Endocrine pharmacology of antiestrogens as antitumor agents. Endocrine Rev 11:578–610, 1990

    Google Scholar 

  23. Katzenellenbogen BS: Antiestrogen resistance: Mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst 83:1434–1435, 1991

    Google Scholar 

  24. Fuqua SA: Where is the lesion in hormone-independent breast cancer? J Natl Cancer Inst 84:554–555, 1992

    Google Scholar 

  25. Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M: Acquired tamoxifen resistance: Correlation with reduced breast tumor levels of tamoxifen and isomerization oftrans-4-hydroxy tamoxifen. J Natl Cancer Inst 83:1477–1482, 1991

    Google Scholar 

  26. Beck CA, Weigel NL, Edwards DP: Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol 6:607–620, 1992

    Google Scholar 

  27. Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DP: The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA 90:4441–4445, 1993

    Google Scholar 

  28. Estes PA, Suba EJ, Lawler-Heavner J, Elashry-Stowers D, Wei LL, Sullivan EP, Toft DO, Horwitz KB, Edwards DP: Immunological analysis of progesterone receptors in human breast cancer. I. Purification of transformed receptors and production of monoclonal antibodies. Biochemistry 26:6250–6262, 1987

    Google Scholar 

  29. El-Ashry D, Oñate S, Nordeen SK, Edwards DP: Human progesterone receptor complexed with the antagonist RU 486 binds to a hormone response element in a structurally altered form. Mol Endocrinol 3:1545–1558, 1989

    Google Scholar 

  30. Nordeen SK, Kühnel B, Lawler-Heavner J, Barber DA, Edwards DP: A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol 3:1270–1278, 1989

    Google Scholar 

  31. Nordeen SK, Green III PP, Fowlkes DM: A rapid, sensitive and inexpensive assay for chloramphenicol acetyl transferase. DNA 6:173–178, 1987

    Google Scholar 

  32. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogenregulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603–1614, 1990

    Google Scholar 

  33. Sheridan PL, Krett NL, Gordon JA, Horwitz KB: Human progesterone receptor transformation and nuclear down-regulation are independent of phosphorylation. Mol Endocrinol 2:1329–1342, 1988

    Google Scholar 

  34. Sheridan PL, Evans RM, Horwitz KB: Phosphotryptic peptide analysis of human progesterone receptors. J Biol Chem 264:6520–6528, 1989

    Google Scholar 

  35. Edwards DP, Kühnel B, Estes PA, Nordeen SK: Human progesterone receptor binding to mouse mammary tumor virus deoxynucleic acid: dependence on hormone and nonreceptor nuclear factor(s). Mol Endocrinol 3:3381–391, 1989

    Google Scholar 

  36. Bagchi MK, Tsai SY, Tsai M-J, O'Malley BW: Progesterone enhances target gene transcription by receptor free of heat shock proteins hsp90, hsp56 and hsp70. Mol Cell Biol 11:4998–5004, 1991

    Google Scholar 

  37. Meyer M-E, Pornon A, Ji J, Bocquel M-T, Chambon P, Gronemeyer H: Agonistic and antagonistic activities of RU486 on functions of the human progesterone receptor. EMBO J 9:3923–3932, 1990

    Google Scholar 

  38. Philibert D: RU 38486: An original multifaceted antihormonein vivo.In Agarwal MK (ed) Adrenal Steroid Antagonism. Walter de Gruyter & Co, Berlin, New York, 1984, pp 77–101

    Google Scholar 

  39. Horwitz KB: The molecular biology of RU486: Is there a role for antiprogestins in treatment of breast cancer? Endocrine Rev 13:146–163, 1992

    Google Scholar 

  40. DeMarzo AM, Oñate SA, Nordeen SK, Edwards DP: Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor. Biochemistry 31:10491–10501, 1992

    Google Scholar 

  41. Guiochon-Mantel A, Loosfelt H, Ragot T, Bailly A, Atger M, Misrahi M, Perricaudet M, Milgrom E: Receptors bound to antiprogestin form abortive complexes with hormone responsive elements. Nature 336:695–698, 1988

    Google Scholar 

  42. Klein-Hitpass L, Cato ACB, Henderson D, Ryffel GU: Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acids Res 19:1227–1234, 1991

    Google Scholar 

  43. Slater EP, Cato ACB, Karin M, Baxter JD, Beato M: Progesterone induction of metallothionein-IIA gene expression. Mol Endocrinol 2:485–491, 1988

    Google Scholar 

  44. Weigel NL, Carter TH, Schrader WT, O'Malley BW: Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase duringin vitro transcription assays. Mol Endocrinol 6:8–14, 1992

    Google Scholar 

  45. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn T-F, McLachlan JA, Korach KS: Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658–4662, 1992

    Google Scholar 

  46. Rangarajan PN, Umesono K, Evans RM: Modulation of glucocorticoid receptor function by protein kinase A. Mol Endocrinol 6:1451–1457, 1992

    Google Scholar 

  47. Somers JP, DeFranco DB: Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement. Mol Endocrinol 6: 26–34, 1992

    Google Scholar 

  48. Curtis SW, Korach KS: Uterine estrogen receptor-DNA complexes: Effects of different ERE sequences, ligands, and receptor forms. Mol Endocrinol 4:276–286, 1990

    Google Scholar 

  49. Rodriguez R, Weigel NL, O'Malley BW, Schrader WT: Dimerization of the chicken progesterone receptorin vitro can occur in the absence of hormone and DNA. Mol Endocrinol 4:1782–1790, 1990

    Google Scholar 

  50. Glass CK, Holloway JM: Regulation of gene expression by the thyroid hormone receptor. Biochim Biophys Acta 1032:157–176, 1990

    Google Scholar 

  51. Rao KUS, Peralta WD, Greene GL, Fox CF: Cellular progesterone receptor phosphorylation in response to ligands activating protein kinases. Biochem Biophys Res Commun 146:1357–1365, 1987

    Google Scholar 

  52. Simons SS Jr, Oshima H, Szapary D: Higher levels of control: Modulation of steroid hormone-regulated gene transcription. Mol Endocrinol 6:995–1002, 1992

    Google Scholar 

  53. Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai M-J, O'Malley BW: Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 267:19513–19520, 1992

    Google Scholar 

  54. Weigel NL, Beck CA, Estes PA, Prendergast P, Altmann M, Christensen K, Edwards DP: Ligands induce conformational changes in the carboxy-terminus of progesterone receptors which are detected by a sitedirected antipeptide monoclonal antibody. Mol Endocrinol 6:1585–1597, 1992

    Google Scholar 

  55. Reese JC, Katzenellenbogen BS: Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: Studies using human estrogen receptor overexpressed in mammalian cells. Nucleic Acids Res 19:6595–6602, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology (B216), University of Colorado Health Sciences Center, 4200 East Ninth Avenue, 80262, Denver, CO, USA

    Dean P. Edwards, Nancy L. Weigel, Steven K. Nordeen & Candace A. Beck

  2. Cell Biology Department, Baylor College of Medicine, 77030, Houston, Texas, USA

    Nancy L. Weigel

Authors
  1. Dean P. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy L. Weigel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven K. Nordeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Candace A. Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, D.P., Weigel, N.L., Nordeen, S.K. et al. Modulators of cellular protein phosphorylation alter thetrans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Tr 27, 41–56 (1993). https://doi.org/10.1007/BF00683192

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00683192

Key words

Search

Navigation